Paper41874166
Establishment of a Sensitized 3D Spheroid Cancer Cell Model for Enhanced Anti-Cancer Drug Discovery.
Tan EW and 4 others. Methods Protoc, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Establishment of a Sensitized 3D Spheroid Cancer Cell Model for Enhanced Anti-Cancer Drug Discovery. Papers, record 41874166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41874166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Establishment of a Sensitized 3D Spheroid Cancer Cell Model for Enhanced Anti-Cancer Drug Discovery.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GRTIN-ECR-SBMDC-05-2024 | Sunway University | PubMed | ||
| GRTIN-RAG-SBMDC-05-2025 | Sunway University | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36089610 | Three-dimensional in vitro culture models in oncology research. | Cell Biosci | 2022 | https://conductscience.org/library/papers/36089610 | PubMed |
| 2 | 17562441 | Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model. | Acta Oncol | 2007 | https://conductscience.org/library/papers/17562441 | PubMed |
| 3 | 36297203 | Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. | Pathogens | 2022 | https://conductscience.org/library/papers/36297203 | PubMed |
| 4 | 35082905 | Alpha-Mangostin Activates MOAP-1 Tumor Suppressor and Mitochondrial Signaling in MCF-7 Human Breast Cancer Cells. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35082905 | PubMed |
| 5 | 39577429 | Deep-supercooling preservation of stem cell spheroids for chondral defect repairment. | Stem Cell Reports | 2024 | https://conductscience.org/library/papers/39577429 | PubMed |
| 6 | 35421577 | New synthetic phenylquinazoline derivatives induce apoptosis by targeting the pro-survival members of the BCL-2 family. | Bioorg Med Chem Lett | 2022 | https://conductscience.org/library/papers/35421577 | PubMed |
| 7 | 22162252 | In vitro three-dimensional (3D) models in cancer research: an update. | Mol Carcinog | 2013 | https://conductscience.org/library/papers/22162252 | PubMed |
| 8 | 30367820 | 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. | Biotechnol Bioeng | 2019 | https://conductscience.org/library/papers/30367820 | PubMed |
| 9 | 32377840 | Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1. | J Cancer Res Clin Oncol | 2020 | https://conductscience.org/library/papers/32377840 | PubMed |
| 10 | 33663530 | Challenges of applying multicellular tumor spheroids in preclinical phase. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/33663530 | PubMed |
| 11 | 34830082 | 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830082 | PubMed |
| 12 | 36778905 | Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review. | ADMET DMPK | 2023 | https://conductscience.org/library/papers/36778905 | PubMed |
| 13 | 35578327 | Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines. | Cancer Metab | 2022 | https://conductscience.org/library/papers/35578327 | PubMed |
| 14 | 35163092 | Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163092 | PubMed |
| 15 | 39490437 | Multicellular tumor spheroids: A convenient in vitro model for translational cancer research. | Life Sci | 2024 | https://conductscience.org/library/papers/39490437 | PubMed |
| 16 | 36971997 | Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/36971997 | PubMed |
| 17 | 37817581 | A tumour-spheroid manufacturing and cryopreservation process that yields a highly reproducible product ready for direct use in drug screening assays. | J R Soc Interface | 2023 | https://conductscience.org/library/papers/37817581 | PubMed |
| 18 | 28871147 | Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment. | Sci Rep | 2017 | https://conductscience.org/library/papers/28871147 | PubMed |
| 19 | 36862289 | Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer. | BioDrugs | 2023 | https://conductscience.org/library/papers/36862289 | PubMed |
| 20 | 36635457 | Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. | Gene Ther | 2023 | https://conductscience.org/library/papers/36635457 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| MOAP1 | 64112 | PubTator's text mining | https://conductscience.org/library/genes/64112 | NCBI Gene |
| RASSF1 | 11186 | PubTator's text mining | https://conductscience.org/library/genes/11186 | NCBI Gene |
| TSPO | 706 | PubTator's text mining | https://conductscience.org/library/genes/706 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41874166
GET https://conductscience.org/api/papers/v1/41874166/references?page=2